Zhong Ji Longevity Science (HKG:0767) forecasts it will swing to a loss of between HK$32 million and HK$35 million in 2024 from a profit of HK$2.3 million in 2023, according to a Wednesday filing with the Hong Kong bourse.
The financial and longevity science research company attributes the foreseen loss to one-off legal and service fees of HK$20.4 million, as well as marketing expenses, and material restructuring costs, the filing said.
Zhong Ji Longevity Science expects to release full-year results on or before March 28.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。